Kadimastem jumps on Merck Serono collaboration

Merck will use Kadimastem's platform to scan drugs for multiple sclerosis treatment

Kadimastem Ltd. (TASE: KDST) drew a great deal of attention today after reporting that it had signed a cooperation agreement with Merck Serono for scanning drugs as potential treatments for multiple sclerosis and other neurodegenerative diseases.

Kadimastem will use its unique platform for Merck Serono, Merck's biopharmaceutical division, in the scanning of potential new drugs.

Kadimasten has developed technologies for stem cell differentiation for oligodendrocytes, cells required by the brain in order to produce myelin for insulation of nerve fibers. In multiple sclerosis, oligodendrocytes are destroyed by the immune system. Kadimasten also has the capability to generate astrocytes from stem cells. Astrocytes are support cells that have been found to be involved in neurodegenerative diseases.

Soon after the signing of the contract, Merck will make an initial payment to Kadimasten; additional payments will be paid according to milestones that have been set. The deal is consistent with Kadimasten's strategy of generating revenue in the short term and tightening its connections with major international pharmaceutical firms for drug scanning projects.

Kadimasten CEO Yossi Ben-Yossef said, "Cooperation with Merck strengthens the fruitful connection between the two companies, and constitutes a vote of confidence in Kadimasten and its innovative technology. The fact that we recently signed a contract for drug scanning with another major pharmaceutical firm indicates the scientific strength and maturity of our technology. It reflects growing realization that we are able to provide a significant addition to the drug development process and to shorten their development times."

Published by Globes [online], Israel business news - www.globes-online.com - on August 3, 2014

© Copyright of Globes Publisher Itonut (1983) Ltd. 2014

Tel Aviv Stock Exchange credit: Shutterstock TASE tumbles in Wall Street's wake

Dual-listed stocks have again been hard hit, but the banks are also down sharply.

Donald Trump and Benjamin Netanyahu credit: Avi Ohayon Netanyahu due in Washington to discuss tariffs

According to news website Axios, Prime Minister Benjamin Netanyahu will be the first leader to meet President Trump after the latter's announcement of sweeping import tariffs.

Yoni Assia CEO eToro Credit: PR eToro defers IPO amid market turmoil

The online trading platform had planned to begin meetings with investors this week.

Minister of Finance Bezalel Smotrich credit: Shlomi Yosef Smotrich meets wrong man in Washington

Minister of Finance Bezalel Smotrich tried to persuade Secretary of the Treasury Scott Bessent to soften the tariff blow on Israel - only Bessent isn't responsible for the matter.

Unframe founders credit: Yossi Yarom Israeli AI enterprise platform co Unframe raises $50m

Unframe’s turnkey AI solutions enable companies to solve any enterprise AI use case at scale with fully functional, customized AI solutions for businesses in a matter of hours, rather than months.

Combatica credit: Combatica Combatica launches next-gen VR AI training platform

The Israeli company's virtual reality platform includes 50 AI generated scenarios, seven maps and even situations for operating night vision.

Shekel credit: Shutterstock Vladirina 32 Shekel volatility after US tariffs announcement

The shekel is weakening sharply against the euro, which is gaining following the unveiling of Donald Trump's tariffs plan.

Minister of Finance Bezalel Smotrich credit: Noam Moskovitz Knesset Spokesperson Treasury assesses potential damage to Israel's US exports

Israel will be charged a higher tariff on its exports to the US - its biggest export customer - than Turkey and the UAE.

Iranian flag credit: Shutterstock Why inflation haunts Iran

With a month-on-month increase of 3.3% and an annual rate of 37.1%, inflation reflects the struggles of millions of Iranians.

APM merges with lawyers from Doron, Tikotzky Kantor, Gutman credit: Eyal Merilos APM merges with 12 lawyers from Doron, Tikotzky Kantor, Gutman

With the addition of these 12 lawyers, Amit Pollak Matalon & Co. will now have 135 lawyers.

US President Donald Trump credit: Reuters Sipa USA Israel on list as Trump unveils tariffs

Relatively low reciprocal tariffs will be imposed on Israeli goods sold in the US.

Deflated unicorn credit: Shutterstock Big Tech 50 reports more huge falls in startup valuations

Israeli R&D partnership Big Tech 50 reports that an investment of $2 million in Orcam made in 2021, shrank to just $31,000 at the end of 2024.

NextFerm technologies based on yeast credit: NextFerm Food-tech co NextFerm suspends operations

The company, which produces food ingredients in yeast without genetic engineering, cannot pay its debts and is seeking a buyer.

Minister of Finance Bezalel Smotrich credit: Shlomi Yosef OECD sees recovery in growth but high inflation

The OECD Israel Economic Survey 2025 recommends that the Israeli government take several restraining measures, in order to exit the economic storm created by the war.

Dano Ben-Hur credit: Dror Sithakol Statisticians contradict BoI on impact of housing finance deals

The Central Bureau of Statistics insists the impact of 20/80 buy now pay later financing deals on the real estate market and housing prices is minimal.

Governor of the Bank of Israel Amir Yaron  credit: Government Press Office Debt fears top Bank of Israel's concerns

Most unusually, Governor of the Bank of Israel Amir Yaron's press conference last week did not focus on inflation and the impending interest rate decision.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018